Cabozantinib- API Insight, 2018
CITY, Country, 2019-Jul-17 — /EPR Network/ — Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid [read full press release…]
Cabozantinib
Home | Submit Press Release | Nationwide / EPR Network | Free Press Release Distribution | Real Time Press Release Distribution | Travel PR News | EuropaWire
© 2004-2024 Express-Press-Release.Net. Owned by EPR Network LLC. All Rights Reserved. All trade marks and names are owned by their respective owners.
RSS | Privacy | Disclaimer | TOS | Feedback
EPR Network LLC disclaims any content found in press releases published on its network - full disclaimer. Powered by WP. Theme by MH Themes
In the works: Consolidated Press Release Distribution | Social Press Release | Early Bird Press Release